Viridian Therapeutics, Inc.
$19.03
-0.53 (-2.71%)
Price as of Oct 16, 2026 market close
Performance
- 1 Month
- -13.2%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Largest decline max drawdown, since Aug 2026
- -26.5%
Own VRDN?
See how VRDN contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.